Fractalkine: a novel cardiac chemokine?
- PMID: 22012953
- PMCID: PMC3211976
- DOI: 10.1093/cvr/cvr272
Fractalkine: a novel cardiac chemokine?
Comment on
-
Detrimental effect of fractalkine on myocardial ischaemia and heart failure.Cardiovasc Res. 2011 Dec 1;92(3):385-93. doi: 10.1093/cvr/cvr221. Epub 2011 Aug 12. Cardiovasc Res. 2011. PMID: 21840883
References
-
- Xuan W, Liao Y, Chen B, Huang Q, Xu D, Liu Y, et al. Detrimental effect of fractalkine on myocardial ischaemia and heart failure. Cardiovasc Res. 2011;92:385–393. - PubMed
-
- Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, et al. A new class of membrane-bound chemokine with a CX3C motif. Nature. 1997;385:640–644. - PubMed
-
- Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell. 1997;91:521–530. - PubMed
-
- Garton KJ, Gough PJ, Blobel CP, Murphy G, Greaves DR, Dempsey PJ, et al. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1) J Biol Chem. 2001;276:37993–38001. - PubMed
-
- Moatti D, Faure S, Fumeron F, Amara Mel-W, Seknadji P, McDermott DH, et al. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood. 2001;97:1925–1928. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials